Generalizable brain network markers of major depressive disorder across multiple imaging sites

PLoS Biol. 2020 Dec 7;18(12):e3000966. doi: 10.1371/journal.pbio.3000966. eCollection 2020 Dec.

Abstract

Many studies have highlighted the difficulty inherent to the clinical application of fundamental neuroscience knowledge based on machine learning techniques. It is difficult to generalize machine learning brain markers to the data acquired from independent imaging sites, mainly due to large site differences in functional magnetic resonance imaging. We address the difficulty of finding a generalizable marker of major depressive disorder (MDD) that would distinguish patients from healthy controls based on resting-state functional connectivity patterns. For the discovery dataset with 713 participants from 4 imaging sites, we removed site differences using our recently developed harmonization method and developed a machine learning MDD classifier. The classifier achieved an approximately 70% generalization accuracy for an independent validation dataset with 521 participants from 5 different imaging sites. The successful generalization to a perfectly independent dataset acquired from multiple imaging sites is novel and ensures scientific reproducibility and clinical applicability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Algorithms
  • Brain / physiopathology
  • Brain Mapping / methods*
  • Databases, Factual
  • Depressive Disorder, Major / diagnostic imaging*
  • Depressive Disorder, Major / metabolism
  • Depressive Disorder, Major / physiopathology*
  • Female
  • Humans
  • Machine Learning
  • Magnetic Resonance Imaging / methods
  • Male
  • Middle Aged
  • Nerve Net / physiology
  • Neural Pathways
  • Reproducibility of Results
  • Rest / physiology

Grants and funding

This study was conducted under the contract research "Brain/MINDS Beyond" Grant Number JP18dm0307008, supported by the Japan Agency for Medical Research and Development (AMED) while using data obtained from the database project supported by“Development of BMI Technologies for Clinical Application” of the Strategic Research Program for Brain Sciences JP17dm0107044 (AMED). This study was also supported by Grant Number JP18dm0307002, JP18dm0307004, and JP19dm0307009 (AMED). M.K., H.I. and A.Y. were partially supported by the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). K.K. was partially supported by the International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (UTIAS) and JSPS KAKENHI 16H06280 (Advanced Bioimaging Support). H.I. was partially supported by JSPS KAKENHI 18H01098, 18H05302, and 19H05725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.